Aviject 45,5 mg/2 ml indications
Oral
Allergic conditions
Adult: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Child: As maleate: 5-10 yr: Half a 45-mg tablet up to tid; >10 yr: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Elderly: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Oral
Prophylaxis of motion sickness
Adult: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day. Take 1st dose at least 30 min before travelling.
Child: As maleate: 5-10 yr: Half a 45-mg tablet up to tid; >10 yr: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day. Take 1st dose at least 30 min before travelling.
Ophthalmic
Allergic conjunctivitis
Adult: Aviject 45,5 mg/2 ml maleate 0.3% in combination with naphazoline hydrochloride 0.025%: 1 or 2 drops in the affected eye/s up to 4 times a day.
Child: ≥6 yr: Aviject 45,5 mg/2 ml maleate 0.3% in combination with naphazoline hydrochloride 0.025%: 1 or 2 drops in the affected eye/s up to 4 times a day.
Uses of Aviject 45,5 mg/2 ml in details
Aviject 45,5 mg/2 ml is used for treatment of symptoms of allergic rhinitis (e.g. sneezing, runny and itchy nose and eye irritation) and other symptoms of allergy and hay fever.
Aviject 45,5 mg/2 ml description
One of the histamine H1 antagonists with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus. [PubChem]
Aviject 45,5 mg/2 ml dosage
Oral
Allergic conditions
Adult: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Child: As maleate: 5-10 yr: Half a 45-mg tablet up to tid; >10 yr: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Elderly: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day.
Oral
Prophylaxis of motion sickness
Adult: As maleate: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day. Take 1st dose at least 30 min before travelling.
Child: As maleate: 5-10 yr: Half a 45-mg tablet up to tid; >10 yr: Syrup: 15-30 mg bid or tid. Tablet: Up to 45 mg tid. Max: 3 mg/kg/day. Take 1st dose at least 30 min before travelling.
Ophthalmic
Allergic conjunctivitis
Adult: Aviject 45,5 mg/2 ml maleate 0.3% in combination with naphazoline hydrochloride 0.025%: 1 or 2 drops in the affected eye/s up to 4 times a day.
Child: ≥6 yr: Aviject 45,5 mg/2 ml maleate 0.3% in combination with naphazoline hydrochloride 0.025%: 1 or 2 drops in the affected eye/s up to 4 times a day.
Aviject 45,5 mg/2 ml interactions
May mask ototoxicity produced by aminoglycoside antibiotics.
Potentially Fatal: Potentiation of CNS depression by alcohol, sedatives, opioids, barbiturates, hypnotics, narcoleptics. May increase antimuscarinic effect of MAOIs, atropine and TCAs.
Aviject 45,5 mg/2 ml side effects
All medicines can have some unwanted side effects. Sometimes they are serious, most of the time they are not. Your doctor or pharmacist has weighed the risks of using this medicine against
the benefits they expect it will have for you. Do not be alarmed by this list of possible side effects.
You may not experience any of them.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking this medicine.
Tell your pharmacist or doctor if you notice
any of the following and they worry you:
• drowsiness
• nervousness, irritability, incoordination, lack of concentration
• dizziness
• tinnitus (ringing in the ears)
• nausea and vomiting
• difficulty passing urine
Tell your doctor immediately if you notice any of the following:
• changes in your usual behaviour or mood
• severe sedation, confusion or restlessness
• hallucinations
• vision problems
• irregular heart beat
Aviject 45,5 mg/2 ml contraindications
Do not take this medicine if you:
• are taking an antidepressant medicine known as a MAO Inhibitor
• are male and you have an enlarged prostate
Do not take this medicine if you are allergic to it or any of the ingredients listed at the end of this leaflet.
Some symptoms of an allergic reaction include skin rash, itching, asthma, wheezing, shortness of breath or swelling of the fact, lips or tongue,
which may cause difficulty in swallowing or breathing, fainting.
Do not take it after the expiry date (EXP) printed on the pack.
If you take it after the expiry date has passed, it may not work as well.
Do not take it if the packaging is torn or shows signs of tampering.
Do not give this medicine to a premature or newborn baby.
Active ingredient matches for Aviject 45,5 mg/2 ml:
Pheniramine in Turkey.
List of Aviject 45,5 mg/2 ml substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Aviject (Turkey) | |
| Avil (Australia, Bangladesh, Ethiopia, India, Indonesia, Luxembourg, Serbia, Sri Lanka, Turkey) | |
| Syrup; Oral; Pheniramine Maleate 15 mg / 5 ml (Sanofi Aventis) | |
| Tablet; Oral; Pheniramine Maleate 45.3 mg (Sanofi Aventis) | |
| AVIL Capsule/ Tablet / 25mg / 15 units (Sanofi Aventis) | $ 0.05 |
| AVIL Capsule/ Tablet / 50mg / 15 units (Sanofi Aventis) | $ 0.06 |
| Avil 25mg TAB / 15 (Sanofi Aventis) | $ 0.05 |
| Avil 50mg TAB / 10 (Sanofi Aventis) | $ 0.06 |
| Avil 15mg/mL SYR / 100ml (Sanofi Aventis) | $ 0.14 |
| 25 mg x 15's (Sanofi Aventis) | $ 0.05 |
| 50 mg x 15's (Sanofi Aventis) | $ 0.06 |
| 15 mg x 1 mL x 100ml (Sanofi Aventis) | $ 0.14 |
| Avil 25 mg x 100's (Sanofi Aventis) | $ 13.86 |
| AVIL 22.75 MG INJECTION 1 vial / 2 ML injection each (Sanofi Aventis) | $ 0.04 |
| AVIL 25 MG TABLET 1 strip / 15 tablets each (Sanofi Aventis) | $ 0.07 |
| AVIL 50 MG TABLET 1 strip / 15 tablets each (Sanofi Aventis) | $ 0.08 |
| AVIL tab 25 mg x 15's (Sanofi Aventis) | $ 0.05 |
| AVIL tab 50 mg x 15's (Sanofi Aventis) | $ 0.06 |
| AVIL syr 15 mg x 1 mL x 100ml (Sanofi Aventis) | $ 0.14 |
| Avil 22.75mg Injection (Sanofi Aventis) | $ 0.01 |
| Avil 25mg Tablet (Sanofi Aventis) | $ 0.01 |
| Avil 50mg Tablet (Sanofi Aventis) | $ 0.01 |
| Avil - RC | |
| Avil - RC 22.75mg VIAL / 10ml | $ 0.09 |
| Avil 1,25% (Turkey) | |
| Avil 15 mg (Turkey) | |
| Avil 2 ml 45,5 mg (Turkey) | |
| Avil 22,7mg (Turkey) | |
| Avil Retard (Bangladesh, India) | |
| Tablet, Sustained Release; Oral; Pheniramine Maleate 75 mg (Sanofi Aventis) | |
| AVIL RETARD Modified Release Capsule/ Tablet / 75mg / 10 units (Sanofi Aventis) | $ 0.12 |
| Avil Retard 75mg DRAG / 10 (Sanofi Aventis) | $ 0.12 |
| 75 mg x 10's (Sanofi Aventis) | $ 0.12 |
| AVIL RETARD drag 75 mg x 10's (Sanofi Aventis) | $ 0.12 |
| AVIL-RC (India) | |
| 22.75 mg x 10ml (Sanofi Aventis) | $ 0.09 |
| Avil-RC 22.75mg VIAL / 10ml (Sanofi Aventis) | $ 0.09 |
| AVIL-RC inj 22.75 mg x 10ml (Sanofi Aventis) | $ 0.09 |
| Avil-RC 22.75mg VIAL / 10ml (Sanofi Aventis) | $ 0.09 |
| Aviletten (Germany) | |
| Avilettes (Australia) | |
| Avilon (Pakistan) | |
| Avil® | |
| AvilВ® | |
| Cauphe (Turkey) | |
| Daizyn (Turkey) | |
See 76 substitutes for Aviject 45,5 mg/2 ml | |
References
- PubChem. "pheniramine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "pheniramine". http://www.drugbank.ca/drugs/DB01620 (accessed September 17, 2018).
- DTP/NCI. "pheniramine: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Aviject 45,5 mg/2 ml are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Aviject 45,5 mg/2 ml. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
